Amy McQueen1, Enbal Shacham2, Walton Sumner3, E Turner Overton4. 1. Washington University School of Medicine, Department of Medicine, Division of Health Behavior Research, St. Louis MO, USA. amcqueen@dom.wustl.edu. 2. Saint Louis University, College for Public Health and Social Justice, Department of Behavioral Sciences and Health Education, St. Louis MO, USA. 3. Washington University School of Medicine, Department of Medicine, Division of General Medical Sciences, St. Louis MO, USA. 4. University of Alabama at Birmingham, Department of Medicine, Division of Infectious Diseases, Birmingham AL, USA.
Abstract
OBJECTIVES: To examine beliefs, prior use, and interest in using pharmacotherapy among people living with HIV/AIDS (PLWHA). METHODS: Cross-sectional survey of smokers in a midwestern HIV clinic. RESULTS: The sample (N = 146) included 69% men, 82% African Americans, 45% were in precontemplation for quitting, and 46% were interested in using pharmacotherapy. Primary reasons for non-use included cost and a belief that they would be able to quit on their own. Physician assistance was the strongest correlate of prior use. Perceived benefits and self-efficacy were the strongest correlates of willingness to use pharmacotherapy. CONCLUSIONS: Future interventions should address misconceptions, perceived benefits, and self-efficacy for using cessation aids. Physicians should offer pharmacotherapy to all smokers.
OBJECTIVES: To examine beliefs, prior use, and interest in using pharmacotherapy among people living with HIV/AIDS (PLWHA). METHODS: Cross-sectional survey of smokers in a midwestern HIV clinic. RESULTS: The sample (N = 146) included 69% men, 82% African Americans, 45% were in precontemplation for quitting, and 46% were interested in using pharmacotherapy. Primary reasons for non-use included cost and a belief that they would be able to quit on their own. Physician assistance was the strongest correlate of prior use. Perceived benefits and self-efficacy were the strongest correlates of willingness to use pharmacotherapy. CONCLUSIONS: Future interventions should address misconceptions, perceived benefits, and self-efficacy for using cessation aids. Physicians should offer pharmacotherapy to all smokers.
Authors: John R Hughes; Stephen I Rennard; James R Fingar; Sandy K Talbot; Peter W Callas; Karl O Fagerstrom Journal: Nicotine Tob Res Date: 2011-06-07 Impact factor: 4.244
Authors: P K Nicholas; J G Voss; I B Corless; T G Lindgren; D J Wantland; J K Kemppainen; G E Canaval; E F Sefcik; K M Nokes; C A Bain; K M Kirksey; L S Eller; P J Dole; M J Hamilton; C L Coleman; W L Holzemer; N R Reynolds; C J Portillo; E H Bunch; Y-F Tsai; M R Mendez; S M Davis; D M Gallagher Journal: AIDS Care Date: 2007-11
Authors: Daniel Shirley; Laura Thibodeau; Sheryl L Catz; Katryna McCoy; Douglas E Jorenby; Nasia Safdar; James M Sosman Journal: AIDS Care Date: 2017-08-17
Authors: Mackenzie Hosie Quinn; Anna-Marika Bauer; Alex Flitter; Su Fen Lubitz; Rebecca L Ashare; Morgan Thompson; Frank Leone; Robert Gross; Robert Schnoll Journal: Addict Behav Date: 2019-10-22 Impact factor: 3.913